SN
Therapeutic Areas
Cabaletta Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| rese-cel (resecabtagene autoleucel) | Systemic Lupus Erythematosus (SLE) | Phase 1/2 |
Leadership Team at Cabaletta Bio
SB
Samik Basu
Chief Scientific Officer
GB
Gwendolyn Binder
President, Science & Technology
CB
Catherine Bollard
Independent Director
SB
Scott Brun
Independent Director
AP
Aimee Payne
Scientific Advisory Board Member
MC
Michael C. Milone
Scientific Advisory Board Member
JS
Jay Siegel
Scientific Advisory Board Member